19-08-2014, 12:33 PM
Flibanserin is a newly marketed drug, shows affinity for the 5-HT1A and 5-HT2A receptors. Various routes have been designed for synthesis of Flibanserin and development work was carried out to optimize the process.
Flibanserin is a newly marketed drug, shows affinity for the 5-HT1A and 5-HT2A receptors. Various routes have been designed for synthesis of Flibanserin and development work was carried out to optimize the process.